Transcriptional and Distributional Profiling of Microglia in Retinal Angiomatous Proliferation

Anja Schlecht1,2, Julian Wolf1, Stefaniya Boneva1

  • 1Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Insights

Microglia (MG) dominate myeloid cells in retinal angiomatous proliferation (RAP), a form of age-related macular degeneration. These microglia activate immune responses and proliferate but show limited angiogenic potential.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Macular neovascularization type 3, or retinal angiomatous proliferation (RAP), is linked to myeloid cell accumulation.
  • The specific roles of microglia (MG) and blood-derived macrophages (MAC) in RAP remain unclear.

Purpose of the Study:

  • To determine the contribution of MG and MAC to myeloid cell populations at RAP sites.
  • To analyze the transcriptional profile of MG in RAP using RNA sequencing.

Main Methods:

  • Utilized a microglia-specific reporter mouse line and a mouse model for RAP.
  • Employed RNA sequencing to profile MG.
  • Confirmed findings with immunohistochemistry.

Main Results:

  • Microglia (MG) were the predominant myeloid cell type at RAP sites; macrophages (MAC) were scarce in late-stage RAP.
  • RNA sequencing revealed MG upregulated immune-associated genes (chemotaxis, migration) in early RAP and proliferative genes in late RAP.
  • MG showed minimal upregulation of angiomodulatory factors.

Conclusions:

  • Microglia are the primary myeloid cells involved in RAP.
  • MG undergo significant transcriptional changes, enhancing immune functions and proliferation during RAP development.
  • MG possess limited angiogenic potential in the context of RAP.

Related Concept Videos